Download full-text PDF |
Source |
---|
J Neonatal Perinatal Med
May 2024
Otorhinolaryngology Unit, San Filippo Neri Hospital, Rome, Italy.
Recent studies showed that COVID-19 infection can affect cochleo-vestibular system. The possibility of a vertical transmission is controversial. Some studies suggested that it is possible but unlikely, others find no evidence of vertical transmission.
View Article and Find Full Text PDFEur Arch Otorhinolaryngol
August 2024
Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University Hospital Grenoble-Alpes, BP 217, 38043, Grenoble Cedex 09, France.
Objective: To discuss the link between inner ear decompression sickness and patent foramen ovale.
Materials And Methods: Monocentric and retrospective study on decompression sickness of the inner ear requiring hyperbaric chamber treatment, from 2014 to 2021.
Results: Sixty-one patients of inner ear decompression sickness were included in this study.
Laryngoscope
May 2024
Department of Otolaryngology, and Head and Neck Surgery, Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria, Hearing and Balance Laboratory, University of Las Palmas de Gran Canaria, Las Palmas, Spain.
Objectives: Possible beneficial "crosstalk" during cochlear implant stimulation on otolith end organs has been hypothesized. The aim of this case-control study is to analyze the effect of electrical cochlear stimulation on the vestibule (otolith end-organ), when using a cochleo-vestibular implant, comparing vestibular stimulation (VI) and cochlear stimulation (CI).
Methods: Four patients with bilateral vestibulopathy were included.
Front Neurol
September 2022
EA 3450 DevAH - Development, Adaptation and Handicap, Faculty of Medicine, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Background: Fabry disease (FD) is a rare inherited lysosomal storage disorder caused by the deficiency of the enzyme alpha-galactosidase A. This deficiency leads to an accumulation of glycosphingolipids leading to progressive and multisystemic disease, including renal, cardiac, and neurological damages. FD may also have neuro-otological and visual impairments, which can generate postural control alterations, inner ear, and vision being involved in this function.
View Article and Find Full Text PDFOrphanet J Rare Dis
July 2022
Ophthalmology, Department of Sense Organs, University Sapienza of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
Background: Fabry disease (FD) is a rare X-linked, lysosomal storage disorder caused by mutations in the alpha-galactosidase gene and characterized by neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and ocular manifestations. The aim of this study is to characterize morphological, functional and autophagy-lysosome pathway alterations of the ocular surface in FD patients.
Methods: Eleven subjects with a diagnosis of FD and fifteen healthy control subjects were examined.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!